RecruitingNot ApplicableNCT06003127

REcovery From DEXmedetomidine-induced Unconsciousness


Sponsor

Massachusetts General Hospital

Enrollment

12 participants

Start Date

Nov 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This pilot study in healthy volunteers aims to determine if biological sex has an impact on recovery from dexmedetomidine-induced unconsciousness, and if transcranial magnetic stimulation combined with electroencephalography (TMS-EEG) can be used to measure brain complexity during dexmedetomidine sedation without arousing study participants.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Transcranial Magnetic Stimulation-Electroencephalography for people with anesthesia, consciousness, level altered, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscranial Magnetic Stimulation-Electroencephalography

Transcranial magnetic stimulation of the cerebral cortex and measurement of TMS-evoked potentials in the EEG.


Locations(1)

Massachusetts General Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06003127


Related Trials